Hospital Universitari de Tarragona Joan XXIII -ko ikertzaileekin lankidetzan egindako argitalpenak (17)

2024

  1. Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism

    Frontiers in Endocrinology, Vol. 15

  2. Impact of primary aldosteronism on kidney function: Results from the SPAIN-ALDO registry

    Journal of Hypertension, Vol. 42, Núm. 10, pp. 1805-1812

  3. Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register

    Endocrine, Vol. 84, Núm. 2, pp. 683-693

  4. Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry

    High Blood Pressure and Cardiovascular Prevention, Vol. 31, Núm. 1, pp. 43-53

2023

  1. Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomes

    Endocrine Connections, Vol. 12, Núm. 9

  2. Prevalence, risk factors and evolution of diabetes mellitus after treatment in primary aldosteronism. Results from the SPAIN-ALDO registry

    Journal of Endocrinological Investigation, Vol. 46, Núm. 11, pp. 2343-2352

2021

  1. Erratum: Late Recovery of Parathyroid Function after Total Thyroidectomy: A Case-Control Study (Horm Metab Res (2021) 53 DOI: 10.1055/a-1608-1373)

    Hormone and Metabolic Research

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Late Recovery of Parathyroid Function after Total Thyroidectomy: A Case-Control Study

    Hormone and Metabolic Research, Vol. 53, Núm. 10, pp. 654-661

  4. Recovery of parathyroid function in patients with thyroid cancer treated by total thyroidectomy: An analysis of 685 patients with hypoparathyroidism at discharge of surgery

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 6, pp. 398-407

2020

  1. Permanent postoperative hypoparathyroidism: an analysis of prevalence and predictive factors for adequacy of control in a cohort of 260 patients

    Gland Surgery, Vol. 9, Núm. 5, pp. 1380-1388

2019

  1. Correction to: Prevalence and risk factors for hypoparathyroidism following total thyroidectomy in Spain: a multicentric and nation-wide retrospective analysis (Endocrine, (2019), 66, 2, (405-415), 10.1007/s12020-019-02014-8)

    Endocrine

  2. Prevalence and risk factors for hypoparathyroidism following total thyroidectomy in Spain: a multicentric and nation-wide retrospective analysis

    Endocrine, Vol. 66, Núm. 2, pp. 405-415

2014

  1. Downregulation of G protein-coupled receptor kinase 2 levels enhances cardiac insulin sensitivity and switches on cardioprotective gene expression patterns

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1842, Núm. 12, pp. 2448-2456

2013

  1. A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction

    Diabetologia, Vol. 56, Núm. 11, pp. 2524-2537

2008

  1. Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver

    Obesity Surgery, Vol. 18, Núm. 6, pp. 695-701

2007

  1. Adipose tissue expression of the glycerol channel aquaporin-7 gene is altered in severe obesity but not in type 2 diabetes

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 9, pp. 3640-3645